Correlation Between Oncolytics Biotech and Brookfield Business

Can any of the company-specific risk be diversified away by investing in both Oncolytics Biotech and Brookfield Business at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncolytics Biotech and Brookfield Business into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oncolytics Biotech and Brookfield Business Corp, you can compare the effects of market volatilities on Oncolytics Biotech and Brookfield Business and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncolytics Biotech with a short position of Brookfield Business. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncolytics Biotech and Brookfield Business.

Diversification Opportunities for Oncolytics Biotech and Brookfield Business

-0.47

Correlation Coefficient

Oncolytics Biotech  Brookfield Business

Very good diversification

The 3 months correlation between Oncolytics and Brookfield is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and Brookfield Business Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Brookfield Business Corp and Oncolytics Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncolytics Biotech are associated (or correlated) with Brookfield Business. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Brookfield Business Corp has no effect on the direction of Oncolytics Biotech i.e., Oncolytics Biotech and Brookfield Business go up and down completely randomly.

Pair Corralation between Oncolytics Biotech and Brookfield Business

Assuming the 90 days trading horizon Oncolytics Biotech is expected to generate 2.34 times more return on investment than Brookfield Business. However, Oncolytics Biotech is 2.34 times more volatile than Brookfield Business Corp. It trades about 0.09 of its potential returns per unit of risk. Brookfield Business Corp is currently generating about -0.18 per unit of risk. If you would invest  125.00  in Oncolytics Biotech on October 10, 2024 and sell it today you would earn a total of  10.00  from holding Oncolytics Biotech or generate 8.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Oncolytics Biotech  vs.  Brookfield Business Corp

Oncolytics Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oncolytics Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Brookfield Business Corp

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Brookfield Business Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Brookfield Business is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Oncolytics Biotech and Brookfield Business

The main advantage of trading using opposite Oncolytics Biotech and Brookfield Business positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncolytics Biotech position performs unexpectedly, Brookfield Business can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brookfield Business will offset losses from the drop in Brookfield Business' long position.

The idea behind Oncolytics Biotech and Brookfield Business Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.